Sunday, February 2nd, 2025

LHN Limited Announces S$0.02 Dividend Payout: Key Dates for Shareholders in Singapore and Hong Kong






Double Dividend Delight: LHN Limited Announces Final and Special Dividends for 2024


Double Dividend Delight: LHN Limited Announces Final and Special Dividends for 2024

LHN Limited has announced a significant update that is likely to capture the attention of its shareholders and the market at large. The board of directors has recommended the payment of both a final dividend and a special dividend for the financial year ending 30 September 2024. This proposal, subject to shareholder approval at the annual general meeting (AGM) scheduled for 24 January 2025, presents an exciting potential for value addition to shareholders.

Key Dividend Details

  • The proposed final dividend is S\$0.01 (equivalent to HK\$0.0578) per ordinary share.
  • The proposed special dividend is also S\$0.01 (equivalent to HK\$0.0578) per share.
  • Upon approval, the final dividend will be distributed on 21 February 2025, and the special dividend on 30 May 2025.

Special Dividend Options and Scrip Dividend Scheme

Shareholders will have flexibility with the special dividend through the Scrip Dividend Scheme, which allows them to receive the dividend in the form of scrip shares, cash, or a combination of both. This scheme is contingent upon approval from the AGM and the respective stock exchanges’ permissions.

Important Dates for Shareholders

  • For Singapore shareholders, the register of members closes at 5:00 p.m. on 7 February 2025 for the final dividend and at 5:00 p.m. on 10 April 2025 for the special dividend.
  • For Hong Kong shareholders, the register closes between 10-11 February 2025 for the final dividend and between 11-14 April 2025 for the special dividend.

Potential Impact on Share Price

This announcement could influence LHN Limited’s share price positively, as dividend declarations often lead to investor optimism and increased buying interest.

The Board comprises Executive Chairman and Group Managing Director Lim Lung Tieng, Executive Director Lim Bee Choo, and Independent Non-Executive Directors Ch’ng Li-Ling, Yong Chee Hiong, and Chan Ka Leung Gary.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult with a financial advisor before making any investment decisions.




View LHN Historical chart here



China Sunsine Chemical Reports 43% Profit Surge Amid Economic Challenges and Expansion Plans

China Sunsine Chemical Reports Strong Q3 Performance Amid Economic Challenges China Sunsine Chemical Reports Strong Q3 Performance Amid Economic Challenges China Sunsine Chemical Holdings Ltd. has released its business updates for the third quarter...

ESR-LOGOS REIT Announces Key Dates for Preferential Offering and Advanced Distribution

ESR-LOGOS REIT Announces Preferential Offering and Advanced Distribution Dates ESR-LOGOS REIT Announces Preferential Offering and Advanced Distribution Dates ESR-LOGOS REIT has announced significant updates that could potentially impact shareholder value. Key details regarding the...

Clearbridge Health Limited Announces Key Dates for 1.28 Billion Share Rights Issue

Clearbridge Health’s Bold Rights Issue: What Investors Need to Know Clearbridge Health Limited has announced a significant move aimed at bolstering its capital structure through a proposed renounceable non-underwritten rights issue of up to...